Author: FinMar News

At Finmar News, we bring clarity to the complex world of finance. Our mission is to empower individuals and businesses with timely, trustworthy insights into insurance, financial planning, and investment strategies. Whether you're navigating personal finance or steering corporate decisions, our expert analysis and curated updates help you stay informed and ahead of the curve.Founded on a commitment to transparency and relevance, Finmar News is your go-to source for understanding the forces shaping global markets and local economies. We believe financial literacy is the cornerstone of opportunity—and we’re here to make it accessible.

Investors want to know whether Eli Lilly is seeing the same pricing pressures on its blockbuster weight loss drug Zepbound that Novo Nordisk experienced with its…